SlideShare a Scribd company logo
1 of 14
NATIONAL VIRAL HEPATITIS CONTROL PROGRAM
(NVHCP), C.G.
District name -……………………
District Nodal Officer NVHCP-……………………...................
District Testing Center
S. No Indicator Remark
1
Name of Nodal Officer for Testing Center -……………………………………………………….
Contact No.- ………………..
2
Viral Load Testing Facility (Yes/ No, if Yes Mention type TrueNat
or RTPCR )
3
-Viral Load Kit Availability (Yes/ No)
-RD kit Availability (Yes/ No if Yes then mention type Whole
blood/ Serum based)
4 Person responsible for Entry in MIS Portal (DEO/Lab Technician)
5 Training given to LT & DEO (Yes/No)
6 Screening facility available upto DH/CHC/PHC/ HWC other ..
District Treatment Center
S. No Indicator Remark
1
Name of Nodal Officer for Treatment Center -……………………
Contact No.- ………………..
2 Entry in Treatment Card done by Staff nurse / Pharmacist
3
Drug Distribution System-
From Treatment Center or Central distribution
4
Person responsible for entry in NVHCP MIS Portal-
Pharmacist or DEO or Other
5 Peer Supporter Recruitment (Yes/ No)
Training & Capacity Building
S. No Manpower (Training) Remark (Yes/No)
1
Medical Officer (Treatment) appointed in District Treatment
Center
2 Data Entry Operator
3 Lab Technician/MLT
4 Pharmacist
5 Staff Nurse
Maternal Health-ANC
S. No Indicator Remark(April To February)
1
ANC Screening up to which facility center
2 Number of ANC Screened for Hepatitis B
3 Number of pregnant women who are HBsAg positive
4
Number of pregnant women found positive for HBsAg
delivered in institution
5
Number of newborn to pregnant women (found positive for
HBsAg) received HBIG
6 Process of Referral of Positive pregnant women
Interdepartmental Coordination
• National Aids Control Program(NACO)
 High Risk Group Hepatitis B Screening facility in ICTC or ART-
 Positive Patients Referral System-
 Hep B Immunization of negative HRG-
 Responsibility of Positive Patients Portal entry –
• Child Health
 Number of New Born Zero Dose (April To February) -
 HBIG Availability up to which level(also mention quantity)-
• Blood Bank (April To February)
 Number of donors screened for Hep B-
 Number of donors screened for Hep C-
 Positive Patients Referral System-
 Responsibility of Positive Patients Portal entry –
Interdepartmental Coordination
Last DVHMU Meeting conducted – ……/....../……
Vaccination of Health Care Worker
S.
No
Facility level (April To
February)
Number of HCW
Vaccinated
Pending/Reason
1 District Hospital
2 Community Health Center
3 Primary Health Center
4 Sub Center
5 Health & Wellness Center
6 Community Level
High Risk Group Camp
S.
No
HRG Type
(April To
February)
Number of Person Hep B
Screened
Number of Person Hep C
Screened
Vaccination
Status
1 Prisoner
2
HIV Positive
Patients
3 Migrants
4 Truckers
5
Intravenous Drug
Users
6 Others
Hepatitis B & C Drug status
HEPATITIS - B DRUGS
ENTACAVIR 0.5MG ENTACAVIR 1MG TENOFOVIR 300MG RIBAVIRIN 200MG
STOCK
AVAILABLE
EXPIRY DETAILS
STOCK
AVAILABLE
EXPIRY DETAILS
STOCK
AVAILABLE
EXPIRY DETAILS
STOCK
AVAILABLE
EXPIRY DETAILS
……….
HEPATITIS - C DRUGS
DECLATASVIR 60MG SOFOSBUVIR 400MG SOFOSBUVIR 400MG+VELPATASVIR 100MG
STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS
Note**- Stock total in number of tablets.
Important Achievement Photographs
• HRG Camp photographs
• Meeting/CME/Awareness generation photographs
Registers, Treatment Card, Drug Stock
Printed
• Paste Pictures here
IEC Status
(Banners & Posters outside Testing and Treatment
Centers)
• Paste Pictures here
Issues/ Suggestions

More Related Content

Similar to Template Review Meeting NVHCP.............-1.pptx

Surviellance System-Naco
Surviellance System-NacoSurviellance System-Naco
Surviellance System-Naco
Gnanaranjan Das
 
Meaningful Use Stage-2
Meaningful Use Stage-2Meaningful Use Stage-2
Meaningful Use Stage-2
preeti_ipc
 
Cadth 2015 c4 symp 13 april 2015_vooght
Cadth 2015 c4 symp 13 april 2015_vooghtCadth 2015 c4 symp 13 april 2015_vooght
Cadth 2015 c4 symp 13 april 2015_vooght
CADTH Symposium
 
Lab support in hiv treatment and management
Lab support in hiv treatment and managementLab support in hiv treatment and management
Lab support in hiv treatment and management
Abhijit Chaudhury
 
08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarh08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarh
Prabir Chatterjee
 

Similar to Template Review Meeting NVHCP.............-1.pptx (20)

Surviellance System-Naco
Surviellance System-NacoSurviellance System-Naco
Surviellance System-Naco
 
Universal HIV and Hepatitis C Testing in the UCSD Emergency Departments: It T...
Universal HIV and Hepatitis C Testing in the UCSD Emergency Departments: It T...Universal HIV and Hepatitis C Testing in the UCSD Emergency Departments: It T...
Universal HIV and Hepatitis C Testing in the UCSD Emergency Departments: It T...
 
2015 indicator reference guide viral load suppression at 12 months
2015 indicator reference guide   viral load suppression at 12 months2015 indicator reference guide   viral load suppression at 12 months
2015 indicator reference guide viral load suppression at 12 months
 
Meaningful Use Stage-2
Meaningful Use Stage-2Meaningful Use Stage-2
Meaningful Use Stage-2
 
Hcv
HcvHcv
Hcv
 
E R Pep Sept 2009
E R Pep Sept 2009E R Pep Sept 2009
E R Pep Sept 2009
 
Catchment area meeting HIV report.pptx
Catchment area meeting HIV report.pptxCatchment area meeting HIV report.pptx
Catchment area meeting HIV report.pptx
 
Notes on sensitization workshop on recent initiatives.
Notes on sensitization workshop on recent initiatives.Notes on sensitization workshop on recent initiatives.
Notes on sensitization workshop on recent initiatives.
 
Cadth 2015 c4 symp 13 april 2015_vooght
Cadth 2015 c4 symp 13 april 2015_vooghtCadth 2015 c4 symp 13 april 2015_vooght
Cadth 2015 c4 symp 13 april 2015_vooght
 
Lab support in hiv treatment and management
Lab support in hiv treatment and managementLab support in hiv treatment and management
Lab support in hiv treatment and management
 
safebloodtransfusion-170515065006.pdf
safebloodtransfusion-170515065006.pdfsafebloodtransfusion-170515065006.pdf
safebloodtransfusion-170515065006.pdf
 
Safe Blood Transfusion
Safe Blood TransfusionSafe Blood Transfusion
Safe Blood Transfusion
 
Hematovigilance / Haemovigilance Pranav
Hematovigilance / Haemovigilance PranavHematovigilance / Haemovigilance Pranav
Hematovigilance / Haemovigilance Pranav
 
Template for medical college core committee
Template  for medical college core committeeTemplate  for medical college core committee
Template for medical college core committee
 
Blood Transfusion, Blood Products, and Safety.pptx
Blood Transfusion, Blood Products, and Safety.pptxBlood Transfusion, Blood Products, and Safety.pptx
Blood Transfusion, Blood Products, and Safety.pptx
 
08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarh08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarh
 
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
 
Proposed changes to the PPS protocol for discussion. Carl Suetens (ECDC)
Proposed changes to the PPS protocol for discussion. Carl Suetens (ECDC)Proposed changes to the PPS protocol for discussion. Carl Suetens (ECDC)
Proposed changes to the PPS protocol for discussion. Carl Suetens (ECDC)
 
Guidances
GuidancesGuidances
Guidances
 
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umairNucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
Nucliec Acid Testing in Blood and solid organ Donor Screening by dr umair
 

More from HarishankarSharma27

Approach to Testicular Biopsy.........pptx
Approach to Testicular Biopsy.........pptxApproach to Testicular Biopsy.........pptx
Approach to Testicular Biopsy.........pptx
HarishankarSharma27
 
17_HBV_treatment_3 _special situation..............ppt
17_HBV_treatment_3 _special situation..............ppt17_HBV_treatment_3 _special situation..............ppt
17_HBV_treatment_3 _special situation..............ppt
HarishankarSharma27
 
Muscles of Forearm......................ppt
Muscles of Forearm......................pptMuscles of Forearm......................ppt
Muscles of Forearm......................ppt
HarishankarSharma27
 
mmmt ovary ppt final..................pptx
mmmt ovary ppt final..................pptxmmmt ovary ppt final..................pptx
mmmt ovary ppt final..................pptx
HarishankarSharma27
 
ACUTE LEUKEMIA CME FINAL............pptx
ACUTE LEUKEMIA CME FINAL............pptxACUTE LEUKEMIA CME FINAL............pptx
ACUTE LEUKEMIA CME FINAL............pptx
HarishankarSharma27
 
Burns & its Physiotherapy Management..pptx
Burns & its Physiotherapy Management..pptxBurns & its Physiotherapy Management..pptx
Burns & its Physiotherapy Management..pptx
HarishankarSharma27
 
FLOWCYTOMETRY........................pptx
FLOWCYTOMETRY........................pptxFLOWCYTOMETRY........................pptx
FLOWCYTOMETRY........................pptx
HarishankarSharma27
 
apoptosis.............................pptx
apoptosis.............................pptxapoptosis.............................pptx
apoptosis.............................pptx
HarishankarSharma27
 
AUTISM1..............................pptx
AUTISM1..............................pptxAUTISM1..............................pptx
AUTISM1..............................pptx
HarishankarSharma27
 
Brunnstrom Approach…..................pptx
Brunnstrom Approach…..................pptxBrunnstrom Approach…..................pptx
Brunnstrom Approach…..................pptx
HarishankarSharma27
 
DOC-20231211-WA0184..................pptx
DOC-20231211-WA0184..................pptxDOC-20231211-WA0184..................pptx
DOC-20231211-WA0184..................pptx
HarishankarSharma27
 
Worst is best good no one new..............
Worst is best good no one new..............Worst is best good no one new..............
Worst is best good no one new..............
HarishankarSharma27
 
New best dist .................do ur ppt
New best dist .................do ur pptNew best dist .................do ur ppt
New best dist .................do ur ppt
HarishankarSharma27
 
DENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptx
DENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptxDENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptx
DENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptx
HarishankarSharma27
 
module-15-unfccc-ipcc good characteristics features very nice presentation.ppt
module-15-unfccc-ipcc good characteristics features very nice presentation.pptmodule-15-unfccc-ipcc good characteristics features very nice presentation.ppt
module-15-unfccc-ipcc good characteristics features very nice presentation.ppt
HarishankarSharma27
 

More from HarishankarSharma27 (20)

Approach to Testicular Biopsy.........pptx
Approach to Testicular Biopsy.........pptxApproach to Testicular Biopsy.........pptx
Approach to Testicular Biopsy.........pptx
 
17_HBV_treatment_3 _special situation..............ppt
17_HBV_treatment_3 _special situation..............ppt17_HBV_treatment_3 _special situation..............ppt
17_HBV_treatment_3 _special situation..............ppt
 
Muscles of Forearm......................ppt
Muscles of Forearm......................pptMuscles of Forearm......................ppt
Muscles of Forearm......................ppt
 
mmmt ovary ppt final..................pptx
mmmt ovary ppt final..................pptxmmmt ovary ppt final..................pptx
mmmt ovary ppt final..................pptx
 
ACUTE LEUKEMIA CME FINAL............pptx
ACUTE LEUKEMIA CME FINAL............pptxACUTE LEUKEMIA CME FINAL............pptx
ACUTE LEUKEMIA CME FINAL............pptx
 
Burns & its Physiotherapy Management..pptx
Burns & its Physiotherapy Management..pptxBurns & its Physiotherapy Management..pptx
Burns & its Physiotherapy Management..pptx
 
topic seminar sudha-1...............pptx
topic  seminar sudha-1...............pptxtopic  seminar sudha-1...............pptx
topic seminar sudha-1...............pptx
 
FLOWCYTOMETRY........................pptx
FLOWCYTOMETRY........................pptxFLOWCYTOMETRY........................pptx
FLOWCYTOMETRY........................pptx
 
09_HBV_natural history......======....ppt
09_HBV_natural history......======....ppt09_HBV_natural history......======....ppt
09_HBV_natural history......======....ppt
 
2.CELLULAR DEGENERATION AND....... INFILTRATION-1.ppt
2.CELLULAR DEGENERATION AND....... INFILTRATION-1.ppt2.CELLULAR DEGENERATION AND....... INFILTRATION-1.ppt
2.CELLULAR DEGENERATION AND....... INFILTRATION-1.ppt
 
apoptosis.............................pptx
apoptosis.............................pptxapoptosis.............................pptx
apoptosis.............................pptx
 
AUTISM1..............................pptx
AUTISM1..............................pptxAUTISM1..............................pptx
AUTISM1..............................pptx
 
Brunnstrom Approach…..................pptx
Brunnstrom Approach…..................pptxBrunnstrom Approach…..................pptx
Brunnstrom Approach…..................pptx
 
GENETICS ppt...................... -KP.ppt
GENETICS ppt...................... -KP.pptGENETICS ppt...................... -KP.ppt
GENETICS ppt...................... -KP.ppt
 
DOC-20231211-WA0184..................pptx
DOC-20231211-WA0184..................pptxDOC-20231211-WA0184..................pptx
DOC-20231211-WA0184..................pptx
 
Anthropometry me achcha .............pptx
Anthropometry me achcha .............pptxAnthropometry me achcha .............pptx
Anthropometry me achcha .............pptx
 
Worst is best good no one new..............
Worst is best good no one new..............Worst is best good no one new..............
Worst is best good no one new..............
 
New best dist .................do ur ppt
New best dist .................do ur pptNew best dist .................do ur ppt
New best dist .................do ur ppt
 
DENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptx
DENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptxDENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptx
DENTAL CONDITIONS neww by Dr VR bhagat renowned pediateician.pptx
 
module-15-unfccc-ipcc good characteristics features very nice presentation.ppt
module-15-unfccc-ipcc good characteristics features very nice presentation.pptmodule-15-unfccc-ipcc good characteristics features very nice presentation.ppt
module-15-unfccc-ipcc good characteristics features very nice presentation.ppt
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 

Recently uploaded (20)

Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 

Template Review Meeting NVHCP.............-1.pptx

  • 1. NATIONAL VIRAL HEPATITIS CONTROL PROGRAM (NVHCP), C.G. District name -…………………… District Nodal Officer NVHCP-……………………...................
  • 2. District Testing Center S. No Indicator Remark 1 Name of Nodal Officer for Testing Center -………………………………………………………. Contact No.- ……………….. 2 Viral Load Testing Facility (Yes/ No, if Yes Mention type TrueNat or RTPCR ) 3 -Viral Load Kit Availability (Yes/ No) -RD kit Availability (Yes/ No if Yes then mention type Whole blood/ Serum based) 4 Person responsible for Entry in MIS Portal (DEO/Lab Technician) 5 Training given to LT & DEO (Yes/No) 6 Screening facility available upto DH/CHC/PHC/ HWC other ..
  • 3. District Treatment Center S. No Indicator Remark 1 Name of Nodal Officer for Treatment Center -…………………… Contact No.- ……………….. 2 Entry in Treatment Card done by Staff nurse / Pharmacist 3 Drug Distribution System- From Treatment Center or Central distribution 4 Person responsible for entry in NVHCP MIS Portal- Pharmacist or DEO or Other 5 Peer Supporter Recruitment (Yes/ No)
  • 4. Training & Capacity Building S. No Manpower (Training) Remark (Yes/No) 1 Medical Officer (Treatment) appointed in District Treatment Center 2 Data Entry Operator 3 Lab Technician/MLT 4 Pharmacist 5 Staff Nurse
  • 5. Maternal Health-ANC S. No Indicator Remark(April To February) 1 ANC Screening up to which facility center 2 Number of ANC Screened for Hepatitis B 3 Number of pregnant women who are HBsAg positive 4 Number of pregnant women found positive for HBsAg delivered in institution 5 Number of newborn to pregnant women (found positive for HBsAg) received HBIG 6 Process of Referral of Positive pregnant women
  • 6. Interdepartmental Coordination • National Aids Control Program(NACO)  High Risk Group Hepatitis B Screening facility in ICTC or ART-  Positive Patients Referral System-  Hep B Immunization of negative HRG-  Responsibility of Positive Patients Portal entry – • Child Health  Number of New Born Zero Dose (April To February) -  HBIG Availability up to which level(also mention quantity)-
  • 7. • Blood Bank (April To February)  Number of donors screened for Hep B-  Number of donors screened for Hep C-  Positive Patients Referral System-  Responsibility of Positive Patients Portal entry – Interdepartmental Coordination Last DVHMU Meeting conducted – ……/....../……
  • 8. Vaccination of Health Care Worker S. No Facility level (April To February) Number of HCW Vaccinated Pending/Reason 1 District Hospital 2 Community Health Center 3 Primary Health Center 4 Sub Center 5 Health & Wellness Center 6 Community Level
  • 9. High Risk Group Camp S. No HRG Type (April To February) Number of Person Hep B Screened Number of Person Hep C Screened Vaccination Status 1 Prisoner 2 HIV Positive Patients 3 Migrants 4 Truckers 5 Intravenous Drug Users 6 Others
  • 10. Hepatitis B & C Drug status HEPATITIS - B DRUGS ENTACAVIR 0.5MG ENTACAVIR 1MG TENOFOVIR 300MG RIBAVIRIN 200MG STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS ………. HEPATITIS - C DRUGS DECLATASVIR 60MG SOFOSBUVIR 400MG SOFOSBUVIR 400MG+VELPATASVIR 100MG STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS Note**- Stock total in number of tablets.
  • 11. Important Achievement Photographs • HRG Camp photographs • Meeting/CME/Awareness generation photographs
  • 12. Registers, Treatment Card, Drug Stock Printed • Paste Pictures here
  • 13. IEC Status (Banners & Posters outside Testing and Treatment Centers) • Paste Pictures here